Glass House Brands Inc. (GLAS): Cost of Revenue
$105.02M
Year ended 2025-12-31
+17.9%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $105.02M | +1.5% | 2026-03-24, From 2025-01-01 |
| 2024-12-31 | $103.50M | +29.6% | 2026-03-24, From 2024-01-01 |
| 2023-12-31 | $79.87M | +24.5% | 2025-03-25, From 2023-01-01 |
| 2022-12-31 | $64.16M | +35.4% | 2024-04-02, From 2022-01-01 |
| 2021-12-31 | $47.39M | n/c | 2024-04-02, From 2021-01-01 |
| 2020-12-31 | $29.52M | n/a | 2022-04-01, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $105.02M | +1.5% |
| Marimed Inc. (MRMD) | 2025-12-31 | $101.94M | +7.2% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | $133.52M | +10.7% |
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $46.23M | +21.6% |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | $148.93M | +7.0% |
| Mannatech Inc (MTEX) | 2025-12-31 | $27.08M | +2.5% |
| Fitlife Brands, Inc. (FTLF) | 2025-12-31 | $50.01M | +37.4% |
| Ascend Wellness Holdings, Inc. (AAWH) | 2025-12-31 | $330.90M | -12.3% |
| Cresco Labs Inc. (CRLBF) | 2025-12-31 | $331.28M | -7.9% |
Compare GLAS, MRMD, NAII, NAGE side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗